Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma

Cancer
Michele MilellaFrancesco Cognetti

Abstract

Cyclooxygenase-2 (COX-2) is up-regulated frequently and may constitute a promising therapeutic target in patients with pancreatic ductal adenocarcinoma (PDAC). Patients with advanced PDAC who had progressive disease after gemcitabine-based chemotherapy were eligible for this pilot study. Treatment was comprised of oral celecoxib (400 mg twice daily) and protracted intravenous (i.v.) infusion 5-fluorouracil (5-FU) (200 mg/m(2) per day), both given continuously for a maximum of 9 treatment months, in the absence of disease progression or unacceptable toxicity. Patients were examined weekly for toxicity and were restaged every 6-8 weeks for tumor assessment. Seventeen patients entered the study. Asymptomatic transaminase elevation was the most common toxicity and reached NCI-CTC (version 3.0) Grade 3-4 in 4 of 133 treatment weeks. No other hematologic or nonhematologic toxicity > Grade 2 was observed. Four patients discontinued celecoxib due to upper gastrointestinal tract toxicity. Two confirmed partial responses (durations of 23 weeks and 68 weeks, respectively) and 2 patients with stable disease (durations of 10 weeks and 13 weeks, respectively) were observed for an overall response rate of 12% (95% confidence interval, 0-27%) ...Continue Reading

References

Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J CrownD P Kelsen
Dec 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A DeCaprioS G Arbuck
Jan 1, 1981·Cancer·A B MillerA Winkler
Jun 1, 1994·The British Journal of Surgery·K R PalmerR C Leonard
Mar 1, 1994·Epidemiology·D M Schreinemachers, R B Everson
Apr 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L RothenbergD D Von Hoff
Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusC Svensson
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
May 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AuerbachJ D Ahlgren
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-analysis Group In CancerE Levy
Nov 3, 1998·Alimentary Pharmacology & Therapeutics·A HaycoxT Walley
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-Analysis Group In CancerP Thirion
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HidalgoH Cortes-Funes
Feb 5, 2000·Carcinogenesis·M T Yip-SchneiderC J Sweeney
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M ReniE Villa
Feb 22, 2002·Journal of Cellular Physiology·Yang Cao, Stephen M Prescott
Apr 20, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Alane T Koki, Jaime L Masferrer
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nick MaiseyMark Hill
Aug 8, 2002·Journal of the National Cancer Institute·Kristin E AndersonAaron R Folsom
Feb 27, 2003·The Oncologist·Francois G el-KamarPeter S Kozuch
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan Dmitrovsky
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N K AltorkiA J Dannenberg
Jan 8, 2004·Journal of the National Cancer Institute·Eva S SchernhammerCharles S Fuchs

❮ Previous
Next ❯

Citations

Jan 4, 2008·Cancer Chemotherapy and Pharmacology·M ReniS Grisanti
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Chigusa MorizaneEiichiro Suzuki
Sep 4, 2008·Cancer Chemotherapy and Pharmacology·Yoon Jae KimSi Young Song
Mar 31, 2010·Cancer Chemotherapy and Pharmacology·Kentaro SudoOsamu Yokosuka
Apr 23, 2008·Cancer Metastasis Reviews·Alexios StrimpakosKostas N Syrigos
Apr 26, 2005·Current Oncology Reports·Gregory Friberg, Hedy Lee Kindler
Apr 23, 2013·Journal of Gastrointestinal Cancer·Hend Ahmed El-Hadaad, Hanan Ahmed Wahba
May 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O E RahmaT F Greten
Aug 30, 2008·British Medical Bulletin·S A DanoviN R Lemoine
Mar 2, 2010·Japanese Journal of Clinical Oncology·Akiko TodakaHideharu Tomita
Jun 8, 2006·Journal of the National Cancer Institute·Sabine GröschGerd Geisslinger
Sep 12, 2013·Cancer Letters·Ibrahim Halil SahinChristopher R Garrett
Jan 22, 2011·Gut and Liver·Alexios S StrimpakosMuhammad Wasif Saif
Mar 8, 2014·World Journal of Gastroenterology : WJG·Evan J Walker, Andrew H Ko
Jan 17, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·T Chandramohan ReddyP Reddanna
Dec 29, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Maria Teresa Rizzo
Nov 6, 2010·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Alvaro Arjona-SánchezFrancisco J Padillo
Jan 23, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·M Wasif SaifY-C Cheng
Sep 18, 2009·Cancer Treatment Reviews·Ana CustodioEduardo Díaz-Rubio
Jan 23, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jen-Chung KoYun-Wei Lin
Apr 26, 2008·Critical Reviews in Oncology/hematology·R LongoG Gasparini
Mar 22, 2008·Critical Reviews in Oncology/hematology·Chiara PierantoniStefano Cascinu
Jun 27, 2007·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Gaku MatsumotoAtsutake Okamoto
May 8, 2007·International Journal of Radiation Oncology, Biology, Physics·David K GaffneyKathryn Greven
Oct 21, 2015·Critical Reviews in Oncology/hematology·Adnan M NagrialDesmond Yip
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Soley Bayraktar, Caio M Rocha-Lima
Jul 19, 2006·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·H DoucasD P Berry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.